###begin article-title 0
A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: RER SM ERA JRN. Performed the experiments: RER MG MAG ERA SBA NML. Analyzed the data: RER SM MG MAG ERA ASL RS CS JRN. Contributed reagents/materials/analysis tools: SM RS CS. Wrote the paper: RER SM CS JRN.
###end p 1
###begin p 2
###xml 475 478 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1298 1301 1296 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1572 1575 1569 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
###xml 471 474 <span type="species:ncbi:8790">Emu</span>
###xml 1294 1297 <span type="species:ncbi:8790">Emu</span>
###xml 1302 1306 <span type="species:ncbi:10090">mice</span>
###xml 1568 1571 <span type="species:ncbi:8790">Emu</span>
The phenotypic heterogeneity that characterizes human cancers reflects the enormous genetic complexity of the oncogenic process. This complexity can also be seen in mouse models where it is frequently observed that in addition to the initiating genetic alteration, the resulting tumor harbors additional, somatically acquired mutations that affect the tumor phenotype. To investigate the role of genetic interactions in the development of tumors, we have made use of the Emu-myc model of pre-B and B cell lymphoma. Since various studies point to a functional interaction between Myc and the Rb/E2F pathway, we have investigated the role of E2F activities in the process of Myc-induced lymphomagenesis. Whereas the absence of E2F1 and E2F3 function has no impact on Myc-mediated tumor development, the absence of E2F2 substantially accelerates the time of tumor onset. Conversely, tumor development is delayed by the absence of E2F4. The enhanced early onset of tumors seen in the absence of E2F2 coincides with an expansion of immature B lineage cells that are likely to be the target for Myc oncogenesis. In contrast, the absence of E2F4 mutes the response of the lineage to Myc and there is no expansion of immature B lineage cells. We also find that distinct types of tumors emerge from the Emu-myc mice, distinguished by different patterns of gene expression, and that the relative proportions of these tumor types are affected by the absence of either E2F2 or E2F4. From these results, we conclude that there are several populations of tumors that arise from the Emu-myc model, reflecting distinct populations of cells that are susceptible to Myc-mediated oncogenesis and that the proportion of these cell populations is affected by the presence or absence of E2F activities.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
The diversity of human cancers reflects the variety of genetic changes that cause tumors to emerge and progress. Even for mice engineered with a specific cancer-causing mutation, the resulting tumors are often divergent, reflecting different additional mutations. We wanted to investigate how activities that work together can collaborate in tumorigenesis. Specifically, we are interested in Myc and the E2F family of proteins, intersecting activities that influence a cell's decision to replicate, rest, or die. We made use of an engineered mouse that develops pre-B and B cell lymphoma initiated by Myc and tested whether the loss of particular E2F family members influences these lymphomas. We found that tumor emergence was accelerated by E2F2 loss and delayed by E2F4 loss. We attributed these results to the finding that the mice lacking E2F2 have a greater proportion than usual of the most susceptible, early-stage B lineage cells and the mice lacking E2F4 have fewer of these cells. Distinct tumor types emerged with their relative proportions influenced by E2F2 and E2F4 status. We conclude that the variety of tumors probably reflect different stages of B lymphoid development that respond to Myc and that E2F proteins can influence the proportions of these different stages.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Mullighan1">[1]</xref>
###xml 344 347 344 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Wood1">[4]</xref>
###xml 14 19 <span type="species:ncbi:9606">human</span>
A hallmark of human cancer is genetic complexity, reflecting the acquisition of multiple mutations and gene rearrangements that give rise to the tumor phenotype. Indeed, recent large-scale DNA sequencing efforts have provided direct evidence for this complexity, revealing large numbers of alterations that characterize various tumor types [1]-[4]. Undoubtedly, this genetic complexity of cancer underlies much of the challenge in developing effective therapeutic strategies. Not only is it likely that combinations of drugs will be necessary to match the complexity and effectively treat these tumors but equally important is the ability to identify subgroups of cancers that represent more homogeneous mechanisms of disease.
###end p 6
###begin p 7
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 277 282 <span type="species:ncbi:10090">Mouse</span>
An ability to model the complexity that gives rise to the tumor heterogeneity seen in human cancers would clearly enhance the understanding of the oncogenic process but also would enable the development and testing of combination therapeutics that might match this complexity. Mouse models of cancer have generally employed the use of an activated oncogene or the disruption of a tumor suppressor gene to initiate the oncogenic process. Although this represents a defined genetic alteration, it is also true that in most instances this single event is not sufficient to allow for tumor development. This can be seen in the often protracted latency of tumor development as well as the identification of specific additional genetic alterations that appear in these tumors.
###end p 7
###begin p 8
###xml 100 103 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 133 136 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 156 159 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 205 208 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Adams1">[5]</xref>
###xml 209 212 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Verbeek1">[6]</xref>
###xml 308 311 306 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Cory1">[7]</xref>
###xml 393 396 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Eischen1">[8]</xref>
###xml 96 99 <span type="species:ncbi:8790">Emu</span>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 129 132 <span type="species:ncbi:8790">Emu</span>
###xml 148 153 <span type="species:ncbi:10090">mouse</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
An example of a well-studied genetic model for the analysis of pre-B and B cell lymphoma is the Emu-myc transgenic mouse. In the Emu-myc transgenic mouse c-myc is constitutively expressed in the B lineage [5],[6]. The resulting polyclonal expansion of pre-B cells is initially limited by increased apoptosis [7]. Additional mutations, many of which inactivate the p53 tumor suppressor pathway [8], then arise. This leads to the emergence of a clonal pre-B or B cell lymphoma by six months of age in mice of a mixed C57Bl/6 and 129 strain background.
###end p 8
###begin p 9
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cdk4</italic>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdc25A</italic>
###xml 794 797 794 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Dyson1">[9]</xref>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Nevins1">[11]</xref>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Bates1">[12]</xref>
###xml 1004 1008 1004 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Kowalik1">[13]</xref>
###xml 1492 1495 1492 1495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 1534 1538 1534 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Zindy1">[14]</xref>
Myc has been shown to induce a large number of genes that contribute to cell proliferation. These include the direct transcriptional activation of D cyclin genes, the cdk4 gene encoding the kinase partner for cyclin D, and the Cdc25A gene encoding the phosphatase that removes negative regulatory phosphates from the Cdks. The induction of Cyclin D/cdk4 activity leads directly to the phosphorylation of Rb and thus activation of E2Fs. Numerous studies have demonstrated a central role for the Rb-E2F pathway in the regulation of cellular proliferation. The majority of genes encoding DNA replication and mitotic activities are under the control of E2F proteins. Indeed, recent experiments provide evidence for a role for E2Fs in coordinating transcriptional regulatory events at G1/S and G2/M [9]-[11]. Other work has shown that E2Fs also link this critical proliferative pathway with the p53 response through a capacity to induce the p19ARF/Mdm2 pathway leading to the accumulation of p53 protein [12],[13]. As such, E2Fs provide a mechanism to directly link the control of cell proliferation with the determination of cell fate. In addition to the connection between Myc and E2F in the control of cellular proliferation, Myc expression couples cellular proliferation with the induction of apoptosis under specific growth conditions where survival growth factors are limiting. Myc-induced apoptosis is largely dependent upon p53 signaling and, similar to E2F1, involves the induction of p19ARF, inhibition of Mdm2, and elevated p53 [14].
###end p 9
###begin p 10
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Leone1">[15]</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Sears1">[16]</xref>
###xml 363 367 363 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Berns1">[17]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Leone2">[18]</xref>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 955 959 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 981 985 981 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 989 993 989 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 1242 1245 1242 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 495 500 <span type="species:ncbi:10090">mouse</span>
The shared functional properties of the Myc and E2F transcription factors, coupled with the finding that Myc can induce E2F gene expression [15],[16], raise the possibility that Myc function might be mediated, at least in part, through the action of the E2F transcription factors. Indeed, work by the Bernards laboratory revealed that in addition to targeting p27Kip1, the mitogenic activity of Myc likely involves regulation of E2Fs [17]. This possibility has been more directly assessed using mouse embryo fibroblasts (MEFs) from embryos deleted for specific E2F genes to evaluate the functional relationship between Myc and various E2F proteins [18]. Experiments using these E2F-deficient MEFs showed that the ability of Myc to induce S phase in the absence of other mitogens is severely impaired in MEFs deleted for E2f2 or E2f3, but not E2f1 or E2f4. In contrast, Myc induced apoptosis in primary serum-deprived MEFs was delayed in cells deleted for E2f1, but not affected by E2f2 or E2f3 deletion. Thus, at least in cell culture, the induction of specific E2F activities is an essential downstream event in the Myc pathway that controls cell proliferation versus apoptosis, and some of the functions of Myc, such as the induction of p19ARF and p53 could be explained, at least in part, with one pathway leading through E2F activation.
###end p 10
###begin p 11
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 175 178 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 171 174 <span type="species:ncbi:8790">Emu</span>
To address the significance of the Myc-E2F connection in a relevant, in vivo setting, we have made use of a series of E2F-deficient mouse strains, in combination with the Emu-myc transgenic model of lymphomagenesis (MGI:2448238), to investigate whether deficiencies in E2F1, E2F2, E2F3 or E2F4 (MGI:1857424, 2179111, 2177428 and 1888951) can influence Myc's oncogenic potential. We find that there is a critical role for two E2F activities in affecting the potential for Myc-induced oncogenesis.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 450 460 450 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s001">Figure S1A</xref>
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s011">Text S1</xref>
###xml 560 570 560 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s001">Figures S1</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s002">S2</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s003">S3</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s004">S4</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s005">S5</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s006">S6</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s007">S7</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s008">S8</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s009">S9</xref>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s010">S10</xref>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 710 720 710 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s001">Figure S1B</xref>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 858 868 858 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s001">Figure S1C</xref>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Rempel1">[19]</xref>
###xml 1086 1090 1086 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Lindeman1">[20]</xref>
###xml 1091 1095 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Dagnino1">[21]</xref>
###xml 1143 1149 1143 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1-4</italic>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
As a prelude to the investigation of a role for E2F activity in Myc-mediated oncogenesis, we analyzed the pattern of tissue-specific expression of the various E2F genes. RNA was prepared from selected tissues of wild type mice and then analyzed by quantitative RT-PCR. E2f1 and E2f3 genes were widely expressed whereas expression of the E2f2 gene was largely restricted to the hematopoietic tissues assayed including bone marrow, spleen, and thymus (Figure S1A). Please note that Text S1 (Supporting Materials and Methods) describes the procedures specific to Figures S1, S2, S3, S4, S5, S6, S7, S8, S9, and S10. This restricted E2f2 expression pattern at the RNA level was recapitulated at the protein level (Figure S1B). E2f4, while expressed widely at the RNA level, was also particularly strongly expressed in hematopoietic tissues at the protein level (Figure S1C) [19]. While we did not measure E2F5 in these assays, it has previously been shown that the expression of this E2F family member is restricted to the differentiating epithelial layers of the skin, intestine and brain [20],[21]. As such, we chose to focus our studies on the E2f1-4 genes and gene products.
###end p 13
###begin title 14
A role for E2F2 and E2F4 in Myc-induced lymphomagenesis
###end title 14
###begin p 15
###xml 9 12 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 393 397 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 407 411 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 574 577 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 762 766 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Harris1">[22]</xref>
###xml 5 8 <span type="species:ncbi:8790">Emu</span>
###xml 13 28 <span type="species:ncbi:10090">transgenic mice</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 570 573 <span type="species:ncbi:8790">Emu</span>
###xml 651 656 <span type="species:ncbi:10090">mouse</span>
###xml 818 823 <span type="species:ncbi:10090">mouse</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
Male Emu-myc transgenic mice (backcrossed and maintained in the C57BL/6 strain) were bred into the four different E2F-deficient mouse lines. E2F2, E2F3 and E2F4 cohorts were maintained as C57BL/6x129 while the E2F1 cohort was predominantly C57BL/6 in background. In particular, the E2F3 and E2F4 cohorts required maintenance on a mixed, rather than inbred, background because the yield of the E2f3-null and E2f4-null mice was severely compromised upon inbreeding (data not shown). Sibling mice, wild type, heterozygous or null for a particular E2F gene, and bearing the Emu-myc transgene, were examined weekly for any sign of lymphoma emergence. Each mouse was checked for enlarged lymph nodes, a swollen abdomen, a hunched posture, ruffled fur and/or tachypnea [22]. Upon the appearance of any of these symptoms, the mouse was sacrificed, dissected to identify any lymph node enlargement, and tumor tissue harvested for analysis. For studies assessing the pre-tumor phenotype, mice were sacrificed within three to five weeks after birth and bone marrow and spleen recovered. Such samples were characterized as pre-neoplastic only if lymph node and spleen enlargement was nil or modest at the time of dissection and/or Southern analysis of B lineage cell DNA revealed no specific heavy chain rearrangements indicative of the emergence of tumor clones.
###end p 15
###begin p 16
###xml 55 63 55 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g001">Figure 1</xref>
###xml 89 92 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 122 132 121 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s002">Figure S2A</xref>
###xml 245 255 244 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s002">Figure S2B</xref>
###xml 85 88 <span type="species:ncbi:8790">Emu</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 201 216 <span type="species:ncbi:10090">transgenic mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
Tumor emergence was evaluated in the four E2F cohorts (Figure 1), as well as for our Emu-myc C57BL/6 congenic stock mice (Figure S2A). When the wild type mice in each cohort were compared to the stock transgenic mice, median onsets did diverge (Figure S2B), with earlier onsets associated with greater 129 strain contribution based on breeding history. In spite of this, the overall appearance of each of the wild type curves was similar, with some mice succumbing early and others succumbing late.
###end p 16
###begin title 17
Myc-induced lymphomagenesis is influenced by E2F status.
###end title 17
###begin p 18
###xml 76 79 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 124 127 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 120 127 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1<sup>+/+</sup></italic>
###xml 133 136 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 129 136 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1<sup>+/&#8722;</sup></italic>
###xml 146 149 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 142 149 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1<sup>&#8722;/&#8722;</sup></italic>
###xml 297 300 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 293 300 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3<sup>+/+</sup></italic>
###xml 306 309 305 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 302 309 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3<sup>+/&#8722;</sup></italic>
###xml 319 322 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 315 322 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3<sup>&#8722;/&#8722;</sup></italic>
###xml 432 435 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 428 435 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 441 444 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 437 444 436 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 454 457 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 450 457 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 523 526 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 519 526 518 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 531 534 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 573 576 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 569 576 567 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 581 584 578 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 679 682 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 675 682 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 687 690 683 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 830 833 826 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 826 833 822 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 838 841 833 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 870 873 865 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 866 873 861 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 878 881 872 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 927 930 921 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 923 930 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/+</sup></italic>
###xml 936 939 930 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 932 939 926 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/&#8722;</sup></italic>
###xml 949 952 943 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 945 952 939 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1018 1021 1012 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1014 1021 1008 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1026 1029 1019 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1069 1072 1062 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1065 1072 1058 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/+</sup></italic>
###xml 1077 1080 1069 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1191 1194 1183 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1187 1194 1179 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/+</sup></italic>
###xml 1199 1202 1190 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1213 1216 1204 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1209 1216 1200 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/&#8722;</sup></italic>
###xml 1221 1224 1211 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 72 75 <span type="species:ncbi:8790">Emu</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 527 530 <span type="species:ncbi:8790">Emu</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 577 580 <span type="species:ncbi:8790">Emu</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 683 686 <span type="species:ncbi:8790">Emu</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 834 837 <span type="species:ncbi:8790">Emu</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 874 877 <span type="species:ncbi:8790">Emu</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1022 1025 <span type="species:ncbi:8790">Emu</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1073 1076 <span type="species:ncbi:8790">Emu</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
###xml 1195 1198 <span type="species:ncbi:8790">Emu</span>
###xml 1203 1207 <span type="species:ncbi:10090">mice</span>
###xml 1217 1220 <span type="species:ncbi:8790">Emu</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
(A) Kaplan-Meier survival analysis showing the percentage of tumor-free Emu-myc mice with the indicated E2F1 genotypes (E2f1+/+, E2f1+/-, and E2f1-/- sibling mice in the E2F1 cohort) plotted against the onset of disease. Onset of disease did not vary with E2F1 status. (B) Same as (A) but for E2f3+/+, E2f3+/-, and E2f3-/- sibling mice in the E2F3 cohort. Onset of disease did not vary with E2F3 status. (C) Same as (A) but for E2f2+/+, E2f2+/-, and E2f2-/- sibling mice in the E2F2 cohort. Disease onset was faster in E2f2-/- Emu-myc mice (median age 63 days) than in E2f2+/+ Emu-myc mice (median age 126 days), and the onset curves were significantly different (P<0.0001). E2f2+/- Emu-myc mice exhibited an intermediate onset of disease (median age 92 days), and the onset curve was significantly different from that of the E2f2+/+ Emu-myc mice (P<0.0001) and the E2f2-/- Emu-myc mice (P<0.0001). (D) Same as (A) but for E2f4+/+, E2f4+/-, and E2f4-/- sibling mice in the E2F4 cohort. Disease onset was slower in E2f4-/- Emu-myc mice (median age 375 days) than in E2f4+/+ Emu-myc mice (median age 110 days), and the onset curves were significantly different (P<0.0001). Relative to the E2f4+/+ Emu-myc mice, E2f4+/- Emu-myc mice may have a slightly delayed disease onset (P<0.0465).
###end p 18
###begin p 19
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g001">Figure 1A</xref>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1<sup>+/+</sup></italic>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 194 201 194 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1<sup>+/&#8722;</sup></italic>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1<sup>&#8722;/&#8722;</sup></italic>
###xml 385 388 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 394 398 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Baudino1">[23]</xref>
###xml 450 454 449 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 572 576 571 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 690 694 689 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 778 781 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 841 851 839 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s003">Figure S3A</xref>
###xml 930 933 927 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 944 948 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Langdon1">[24]</xref>
###xml 1022 1026 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 1064 1067 1060 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1217 1227 1213 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s003">Figure S3B</xref>
###xml 1335 1339 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Opavsky1">[25]</xref>
###xml 1370 1373 1365 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1438 1442 1433 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Sidman1">[26]</xref>
###xml 1535 1539 1530 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 1552 1556 1547 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Yamasaki1">[27]</xref>
###xml 1557 1561 1552 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Field1">[28]</xref>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 381 384 <span type="species:ncbi:8790">Emu</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 774 777 <span type="species:ncbi:8790">Emu</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 926 929 <span type="species:ncbi:8790">Emu</span>
###xml 1060 1063 <span type="species:ncbi:8790">Emu</span>
###xml 1068 1083 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1366 1369 <span type="species:ncbi:8790">Emu</span>
As shown in Figure 1A, the loss of E2F1 function did not alter the timing of lymphoma appearance; there was no statistical difference between tumor onset curves when comparing E2f1+/+ (n = 37), E2f1+/- (n = 91) and E2f1-/- (n = 40) mice. The failure of E2F1 status to influence lymphomagenesis conflicts with the earlier finding that E2F1 deficiency delays lymphoma development in Emu-myc mice [23]. That study attributed the delay to a defect in p27Kip1 degradation and reduced Myc-induced proliferation when E2F1 is reduced or absent. In our assessments the level of p27Kip1 protein in splenic B lineage cells did not vary according E2F1 status but rather with progression to disease: p27Kip1 was highest in cells isolated from non-transgenic siblings, reduced in healthy Emu-myc transgenics, and lower still in very sick mice and tumors (Figure S3A). In addition, the accelerated proliferation induced by expression of the Emu-myc transgene [24] was unaffected by E2F1 deficiency: splenic B lineage cells isolated from E2f1 wild type, heterozygous and null Emu-myc transgenic mice all exhibited the same dramatically higher proliferative index when compared to that of cells isolated from non-transgenic siblings (Figure S3B). We note that, analogous to our results, E2F1 deficiency did not alter Myc-induced T cell lymphomagenesis [25]. Given that the timing of Emu-myc-driven tumor development can be influenced by strain background [26] and breeding strategy, we can only surmise that these potential differences or the specific E2f1-null allele [27],[28] used in our studies versus that of Baudino and colleagues are sufficient to account for the discrepant effects of E2F1 deficiency.
###end p 19
###begin p 20
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g001">Figure 1B</xref>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
As shown in Figure 1B, lymphoma onset was also not appreciably influenced by E2F3 status. While the number of E2f3-null animals was low in this study, reflecting the low number of E2f3-null mice born, there is nevertheless no suggestion that E2F3 loss was protective as several E2f3-null mice died before the average age of onset for their wild type siblings.
###end p 20
###begin p 21
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 147 156 147 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g001">Figure 1C</xref>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 163 170 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 368 371 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 364 371 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 403 406 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 399 406 399 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 666 669 666 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 662 669 662 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 796 799 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 792 795 <span type="species:ncbi:8790">Emu</span>
In contrast to the results seen with the E2f1 and E2f3 knockout animals, a deficiency of E2F2 dramatically accelerated the appearance of lymphoma (Figure 1C). The E2f2-/- mice were prone to early tumor onset with tumors appearing on average 60 days earlier than in their wild-type siblings and there was a significant difference (p<0.0001) between the E2f2+/+ and E2f2-/- tumor curves. Notably, the E2f2+/- mice exhibited a median tumor-free span of 92 days and a significantly accelerated course of disease compared to wild-type siblings (p<0.0001). The intermediate phenotype of the E2f2 heterozygotes suggests a degree of haploinsufficiency. In addition, the E2f2+/- lymphomas showed no loss of heterozygosity demonstrating that E2F2 does not behave like a classic tumor suppressor in the Emu-myc context (data not shown).
###end p 21
###begin p 22
###xml 94 103 94 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g001">Figure 1D</xref>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/+</sup></italic>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/&#8722;</sup></italic>
###xml 147 150 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 353 356 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 349 356 349 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/&#8722;</sup></italic>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
Finally, a deficiency in E2F4 also had a dramatic effect on Myc-induced lymphoma development (Figure 1D). A comparison of E2f4+/+, E2f4+/- and E2f4-/- mice revealed that E2f4-/- mice remained tumor-free for significantly longer than siblings (p<0.0001) with a median tumor-free span of 375 days past birth. Lymphoma onset may be modestly delayed in E2f4+/- mice (p = 0.0465).
###end p 22
###begin p 23
###xml 282 291 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s001">Figure S1</xref>
Taken together, these data would suggest roles for two E2F proteins, both positive and negative acting, in affecting the onset of Myc-mediated lymphomas. A role for these two E2F family members also coincides with the prominent expression of these proteins in hematopoetic tissues (Figure S1).
###end p 23
###begin title 24
Loss of E2F2 or E2F4 function does not alter Myc-mediated proliferation or apoptosis
###end title 24
###begin p 25
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Langdon1">[24]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Iritani1">[29]</xref>
###xml 499 508 499 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g002">Figure 2A</xref>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 774 783 774 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g002">Figure 2B</xref>
###xml 785 789 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 973 976 972 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 991 995 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 1011 1014 1010 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1007 1014 1006 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1031 1034 1030 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1027 1034 1026 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1039 1042 1037 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1058 1067 1056 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g002">Figure 2B</xref>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 861 876 <span type="species:ncbi:10090">transgenic mice</span>
###xml 969 972 <span type="species:ncbi:8790">Emu</span>
###xml 1001 1005 <span type="species:ncbi:10090">mice</span>
###xml 1035 1038 <span type="species:ncbi:8790">Emu</span>
Previous work has shown that in the B cell lineage Myc induces proliferation and apoptosis and retards differentiation [24],[29]. As such, the effects of E2F loss of function on Myc oncogenesis could result from alterations in one or more of these processes. To address the potential for differential effects on proliferation, weanling mice were injected with BrdU, three hours later bone marrow was isolated, and the cell cycle distribution of B lineage cells (B220+ CD19+) determined. As shown in Figure 2A, proliferation of B lineage cells was similar for non-transgenic E2f2 wild type and null cells. Importantly, the effect of Myc on cell cycle entry of B lineage cells, with increased S-phase cells and reduced G0/G1 cells, was independent of E2F2 status. As shown in Figure 2B, E2f4 wild type and null B lineage cells were similarly proliferative in non-transgenic mice. As well there was still the expected increase in proliferation associated with bearing the Emu-myc transgene for E2f4-null mice (E2f4-/- compared to E2f4-/- Emu-myc+: p = 0.0002) (Figure 2B). It appears that the acceleration of cell cycle progression driven by Myc in B lineage cells is not significantly affected by the loss of E2F2 or E2F4 activities.
###end p 25
###begin title 26
The cell cycle distribution of pretumorous B lineage cells is not altered by E2F2 or E2F4 status.
###end title 26
###begin p 27
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
(A) The cell cycle distribution of bone marrow B lineage cells (B220+ CD19+) from pretumorous E2F2 cohort mice. The error bars indicate standard deviation. (B) The cell cycle distribution of bone marrow B lineage cells (B220+ CD19+) from pretumorous E2F4 cohort mice. The error bars indicate standard deviation.
###end p 27
###begin p 28
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 218 225 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 319 322 319 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 327 330 326 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 351 354 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 347 354 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 359 362 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 495 498 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 683 690 680 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 802 806 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Evan1">[30]</xref>
###xml 807 811 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Askew1">[31]</xref>
###xml 1286 1295 1283 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s004">Figure S4</xref>
###xml 1366 1369 1362 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1409 1418 1405 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s004">Figure S4</xref>
###xml 1423 1439 1419 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g003">Figure 3A and 3B</xref>
###xml 1510 1513 1506 1509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1506 1513 1502 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 1518 1521 1513 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1630 1639 1625 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g003">Figure 3A</xref>
###xml 1712 1715 1707 1710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1708 1715 1703 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1720 1723 1714 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1818 1827 1812 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g003">Figure 3B</xref>
###xml 1863 1867 1857 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 1973 1977 1967 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 323 326 <span type="species:ncbi:8790">Emu</span>
###xml 355 358 <span type="species:ncbi:8790">Emu</span>
###xml 491 494 <span type="species:ncbi:8790">Emu</span>
###xml 1079 1084 <span type="species:ncbi:10090">mouse</span>
###xml 1362 1365 <span type="species:ncbi:8790">Emu</span>
###xml 1456 1460 <span type="species:ncbi:10090">mice</span>
###xml 1514 1517 <span type="species:ncbi:8790">Emu</span>
###xml 1522 1526 <span type="species:ncbi:10090">mice</span>
###xml 1691 1695 <span type="species:ncbi:10090">mice</span>
###xml 1716 1719 <span type="species:ncbi:8790">Emu</span>
###xml 1724 1728 <span type="species:ncbi:10090">mice</span>
###xml 1878 1882 <span type="species:ncbi:10090">mice</span>
###xml 1983 1987 <span type="species:ncbi:10090">mice</span>
An alteration in the apoptotic potential of Myc could account for the differences in Myc-initiated tumor onset among wild type, E2f2-null and E2f4-null animals. Possibly in E2f2-/- mice apoptosis is reduced whereas in E2f4-/- mice apoptosis is potentiated. Freshly isolated bone marrow B lineage cells (B220+) from E2f2-/- Emu-myc transgenics and E2f4-/- Emu-myc transgenics were found to have comparable percentages of activated caspase-3 positive cells as their wild type and heterozygous Emu-myc siblings, around 0.6%, and all the non-transgenic siblings had less than half this percentage of apoptotic cells (data not shown). Since divergent viability may be masked by clearance in vivo, the survival of B lineage cells under culture conditions where deregulated Myc induces apoptosis was assessed [30],[31]. The bulk of B lineage cells, excepting progenitors upstream of small pre-B cells, was enriched by negative selection from the bone marrow, spleen and mesenteric lymph node. The resulting population of small pre-B cells, immature B cells and mature B cells from each mouse was cultured for eight hours in medium lacking cytokines. The cultured cells were sampled at two-hour intervals, and B220+ cells assessed for viability based on activated caspase 3 and 7-AAD staining (Figure S4). As expected, the decline in viability was faster for cells from Emu-myc transgenics than from non-transgenics (Figure S4 and Figure 3A and 3B). Notably, when mice in the E2F2 cohort were compared, cells from E2f2-/- Emu-myc mice lost viability to a similar extent over eight hours as cells from wild type and heterozygous siblings (Figure 3A). Likewise, in an experiment assessing E2F4 cohort mice, cells from E2f4-/- Emu-myc mice declined in viability similarly to those from their wild type and heterozygous siblings (Figure 3B). Thus, the faster tumor onset for E2f2-deficient mice appears not attributable to a general apoptotic deficiency and the slower tumor onset for E2f4-null mice unlikely the result of increased apoptosis, at least in the small pre-B cells and more mature stages assessed here that constitute the large majority of B lineage cells.
###end p 28
###begin title 29
E2F2 and E2F4 do not influence the viability of pretumorous B lineage cells or the incidence of p19Arf-Mdm2-p53 alterations in Myc-induced lymphomas.
###end title 29
###begin p 30
###xml 717 720 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myc</italic>
###xml 769 772 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 777 783 776 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19ARF</italic>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 713 716 <span type="species:ncbi:8790">Emu</span>
###xml 721 736 <span type="species:ncbi:10090">transgenic mice</span>
(A) Representative experiment assessing the viability of B lineage cells (small pre-B and more mature stages) isolated from pretumorous mice of the E2F2 cohort and cultured in the absence of cytokines. Flow cytometry was used to assess viability over time in culture, with B220+ cells negative for both activated caspase 3 and 7-AAD identified as viable. Error bars show standard deviations. (B) Representative experiment assessing the viability of B lineage cells (small pre-B and more mature stages) isolated from pretumorous mice of the E2F4 cohort and cultured in the absence of cytokines. Error bars show standard deviations. (C) Incidence of p53, p19ARF, and Mdm2 alterations in the lymphomas emerging from Emu-Myc transgenic mice of the indicated E2F genotypes. p53 and p19ARF deletions were identified by Southern blotting, and p53, p19ARF, and Mdm2 overexpression by western blotting. As p19ARF overexpression can result from loss of p53 function, tumors were counted as having p19ARF overexpression only when independent of p53 mutation or deletion. Mdm2 overexpression was counted only if exclusive of defects in p53 or p19ARF.
###end p 30
###begin p 31
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Eischen1">[8]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Zindy1">[14]</xref>
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 330 340 330 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s005">Figures S5</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s006">S6</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s007">S7</xref>
###xml 421 424 420 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 489 498 488 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g003">Figure 3C</xref>
###xml 539 543 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 671 674 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 667 674 666 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 683 686 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 679 686 678 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 740 743 739 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 736 743 735 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 927 931 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Egle1">[32]</xref>
###xml 932 936 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Eischen2">[33]</xref>
###xml 1027 1030 1026 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1023 1030 1022 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 1130 1139 1129 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g003">Figure 3A</xref>
###xml 417 420 <span type="species:ncbi:8790">Emu</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
Myc-mediated tumor emergence is almost invariably associated with a disabling of the ARF-p53 tumor suppressor pathway [8],[14]. Mutations that are indicative of pathway disruption include: p53 deletion, ARF deletion, or overexpression of ARF, Mdm2 or mutant p53. Examples of these disruptions in a sampling of tumors are shown in Figures S5, S6, and S7. Consistent with the earlier studies, tumors from E2F wild type Emu-myc mice showed evidence of disruption of the ARF-Mdm2-p53 pathway (Figure 3C). The largely late-onset lymphomas from E2f4-null mice also demonstrated disruptions in this pathway. Importantly, the spectrum and overall incidence of defects in the E2f2+/- and E2f2-/- lymphomas were very similar to that shown by the E2f2+/+ lymphomas. In contrast, other modifiers of Myc-induced lymphomagenesis such as Bim and Bax relieve or modify the strong selective pressure for functional inactivation of this pathway [32],[33]. That loss of ARF-p53 function was still associated with development of tumors in the E2f2-/- mice further supports the evidence that E2F2 deficiency does not compromise Myc-induced apoptosis (Figure 3A).
###end p 31
###begin title 32
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Expansion of B lineage progenitor populations in E2f2-/- mice
###end title 32
###begin p 33
###xml 370 373 369 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 532 536 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Langdon1">[24]</xref>
###xml 638 641 636 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 800 803 797 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 821 824 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 817 824 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 831 840 828 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g004">Figure 4A</xref>
###xml 933 942 930 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g004">Figure 4B</xref>
###xml 1010 1013 1007 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1006 1013 1003 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 1022 1025 1019 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1018 1025 1015 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 366 369 <span type="species:ncbi:8790">Emu</span>
###xml 634 637 <span type="species:ncbi:8790">Emu</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 796 799 <span type="species:ncbi:8790">Emu</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 1026 1030 <span type="species:ncbi:10090">mice</span>
Given that E2F2 deficiency does not alter the proliferation or apoptosis of pretumorous B lineage cells in response to Myc, we focused on the possibility that there may be a different underlying mechanism driving the accelerated tumor emergence, one involving development of the B lineage and the response to Myc. As noted in one of the earliest descriptions of the Emu-myc model, it is possible that different onsets could reflect different extents of lineage expansion in response to Myc and therefore numbers of vulnerable cells [24]. Overall viable white blood cell number in the bone marrow did not change with E2F2 status while Emu-myc positive mice had modestly higher counts (data not shown). As expected, the B cell lineage expanded as a proportion of the bone marrow in response to the Emu-myc transgene in E2f2+/+ mice (Figure 4A) and the expansion favored less mature over more mature B cells across all three genotypes (Figure 4B). Importantly, there was a similar degree of expansion for the E2f2+/- and E2f2-/- mice.
###end p 33
###begin title 34
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Overall expansion of the B-lineage in response to Myc is not altered by E2F2 status, but E2f2-deficient mice have more progenitor B cells.
###end title 34
###begin p 35
###xml 514 517 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 510 517 510 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 523 526 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 519 526 519 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 536 539 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 532 539 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 681 682 681 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
(A) The percentage of B-lineage cells (B220+) within the bone marrow of normal and pretumorous mice with the indicated genotypes. (B) Proportions of bone marrow B lineage cell populations (B220+), from early to more mature stages, across the E2F2 cohort: surface immunoglobulin negative cells, IgM positive IgD negative cells, IgM positive IgD positive cells, and IgM negative IgD positive cells. (C) For clonogenic pre-B cell progenitor assays, an equivalent number of whole bone marrow cells from 8-week old E2f2+/+, E2f2+/-, and E2f2-/- littermates were plated in methylcellulose formulated for pre-B progenitors. After seven days, the number of progenitors (CFU pre-B) per 5x104 input cells was determined by counting the B lineage colonies that had arisen. (D) The proportion of immature B lineage cells (B220+ CD43+) in the bone marrow of normal and pretumorous E2F2 cohort mice of the indicated genotypes.
###end p 35
###begin p 36
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Kelly1">[34]</xref>
###xml 232 235 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 224 235 223 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc bcl2<sup>&#8722;/&#8722;</sup></italic>
###xml 288 291 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 280 291 278 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc bcl2<sup>+/+</sup></italic>
###xml 418 422 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Kelly1">[34]</xref>
###xml 439 448 436 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc/max41</italic>
###xml 496 499 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 565 569 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Lindeman2">[35]</xref>
###xml 665 686 661 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phospholipase C&#947;2</italic>
###xml 749 753 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Wen1">[36]</xref>
###xml 767 776 759 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g004">Figure 4C</xref>
###xml 916 919 908 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 912 919 904 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 946 949 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 942 949 934 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 1115 1118 1107 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1111 1118 1103 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 1153 1156 1145 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1149 1156 1141 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 1177 1186 1169 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g004">Figure 4D</xref>
###xml 1233 1237 1225 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 1284 1287 1275 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1446 1449 1437 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1442 1449 1433 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 1471 1474 1462 1465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1467 1474 1458 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 1479 1482 1469 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1524 1527 1514 1517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1520 1527 1510 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 1532 1535 1521 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1553 1562 1542 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g004">Figure 4D</xref>
###xml 220 223 <span type="species:ncbi:8790">Emu</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 276 279 <span type="species:ncbi:8790">Emu</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 435 438 <span type="species:ncbi:8790">Emu</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 492 495 <span type="species:ncbi:8790">Emu</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1248 1252 <span type="species:ncbi:10090">mice</span>
###xml 1280 1283 <span type="species:ncbi:8790">Emu</span>
###xml 1297 1301 <span type="species:ncbi:10090">mice</span>
###xml 1475 1478 <span type="species:ncbi:8790">Emu</span>
###xml 1528 1531 <span type="species:ncbi:8790">Emu</span>
###xml 1536 1551 <span type="species:ncbi:10090">transgenic mice</span>
Recent studies have suggested, however, that lymphomagenesis likely initiates in B lineage progenitor cells making the effects of various mutations on progenitor populations particularly relevant [34]. For instance, the Emu-myc bcl2-/- mice develop tumors at the same rate as Emu-myc bcl2+/+ mice despite decreased pre-B, immature B and mature B lymphocytes; significantly, they do have similar numbers of pro-B cells [34]. Similarly, Emu-myc/max41 mice develop lymphoma almost as quickly at Emu-myc mice despite a severe deficit in more mature, peripheral B cells [35]. Conversely, the increased progenitor population of early/large pre-B stage cells exhibited by Phospholipase Cgamma2-deficient mice is associated with accelerated lymphomagenesis [36]. As shown in Figure 4C, CFU pre-B colony assays using bone marrow from non-transgenic E2F2 cohort mice indicate that there were more B lineage progenitors in E2f2-/- marrow (P<0.0001) and E2f2+/- marrow (P = 0.0406) than wild type marrow. The proportion of early B lineage cells (B220+ CD43+) identified by flow cytometry was also greater in non-transgenic E2f2-/- marrow than in non-transgenic E2f2+/+ marrow (P = 0.0008; Figure 4D). The increased proportions of progenitors in E2f2-deficient mice extended into pre-tumorous Emu-myc positive mice: there was the trend, although not statistically significant, for more immature B lineage cells as a proportion of the total bone marrow in E2f2-/- (P = 0.0769) and E2f2+/- Emu-myc transgenics (P = 0.1393) compared to E2f2+/+ Emu-myc transgenic mice (Figure 4D).
###end p 36
###begin p 37
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 78 81 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 127 130 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 218 221 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 214 221 213 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 405 408 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Adams1">[5]</xref>
###xml 410 419 409 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g005">Figure 5A</xref>
###xml 424 442 423 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s008">Figure S8A and S8B</xref>
###xml 551 554 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 559 562 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 568 572 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Sidman2">[37]</xref>
###xml 605 608 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 650 656 647 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53&#8722;/&#8722;</italic>
###xml 682 686 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Hemann1">[38]</xref>
###xml 788 797 785 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g005">Figure 5B</xref>
###xml 842 845 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 838 845 835 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 952 955 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 977 981 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Harris1">[22]</xref>
###xml 1061 1064 1057 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1057 1064 1053 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/&#8722;</sup></italic>
###xml 1145 1148 1140 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 74 77 <span type="species:ncbi:8790">Emu</span>
###xml 547 550 <span type="species:ncbi:8790">Emu</span>
###xml 555 558 <span type="species:ncbi:8790">Emu</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 948 951 <span type="species:ncbi:8790">Emu</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1141 1144 <span type="species:ncbi:8790">Emu</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
Additional analysis revealed that a significant proportion of the E2f2-/- Emu-myc lymphomas were not monoclonal. Assessment of Igh locus rearrangement patterns by Southern analysis indicated that almost 40% of the E2f2-/- tumors were biclonal or oligoclonal whereas tumors from other genotypes, whether in the E2F2 cohort or in other cohorts, were predominantly monoclonal, in agreement with past studies [5] (Figure 5A and Figure S8A and S8B). This degree of oligoclonality was, however, less extensive than that which occurs with the homozygous Emu-myc/Emu-myc mice [37] and when retrovirally-expressed myc was expressed in mice reconstituted with p53-/- hematopoietic stem cells [38]. In addition, several tumors were analyzed by flow cytometry for isotypic surface marker expression (Figure 5B). Seven out of ten tumors emerging from E2f2-/- mice displayed a complex pattern of isotypic surface markers. Such complexity, while not uncommon for Emu-myc lymphomas in general [22], is consistent with multiple clones. Of note, two out of eight tumors from E2f2+/- mice were similarly complex. In contrast, the majority of tumors from other Emu-myc mice displayed single, homogeneous patterns of surface markers and could be clearly classified as being either pro/pre-B or immature B lymphomas.
###end p 37
###begin title 38
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 64 67 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 60 63 <span type="species:ncbi:8790">Emu</span>
Analysis of E2F2 cohort lymphomas shows that some E2f2-null Emu-myc transgenic tumors are polyclonal.
###end title 38
###begin p 39
###xml 475 478 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 471 478 471 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 483 486 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 533 536 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 529 536 528 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 541 544 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 479 482 <span type="species:ncbi:8790">Emu</span>
###xml 537 540 <span type="species:ncbi:8790">Emu</span>
(A) The clonality of lymphomas as indicated by the pattern of immunoglobulin heavy chain rearrangements in Southern blotting. Lymphomas were characterized as monoclonal if there were zero, one, or two bands in addition to the residual genomic band, as biclonal if there were three or four bands in addition to the genomic band, and as oligoclonal if there were five or more bands in addition to the genomic band. (B) Flow cytometric analysis of lymphomas. Top panels, an E2f2+/+ Emu-myc transgenic lymphoma and bottom panels, an E2f2-/- Emu-myc transgenic lymphoma. The tumor cells were stained to identify mature B cell subsets defined by B220 and CD19 and surface expression of IgM and IgD.
###end p 39
###begin p 40
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 78 81 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 486 490 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Smith1">[39]</xref>
###xml 578 581 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 574 581 573 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 787 790 786 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 783 790 782 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 795 798 793 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 913 923 911 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s009">Figure S9A</xref>
###xml 1030 1033 1028 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1026 1033 1024 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 1041 1044 1039 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1037 1044 1035 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 1279 1282 1277 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1275 1282 1273 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 1291 1294 1289 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1287 1294 1285 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 1364 1382 1362 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s009">Figure S9B and S9C</xref>
###xml 74 77 <span type="species:ncbi:8790">Emu</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 791 794 <span type="species:ncbi:8790">Emu</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1183 1188 <span type="species:ncbi:9606">human</span>
Taken together, these findings support the conclusion that in the E2f2-/- Emu-myc mice there is an increased population of B lineage cells susceptible to lymphomagenesis resulting in the occasional emergence of more than one independent tumor. Using a different Myc transgenic system, Cory and colleagues noted the emergence of mixed T cell tumors in their study and concluded that such mixed tumors originated as separate clones and could be expected with a high rate of tumorigenesis [39]. Also consistent with the hypothesis that the enhancement of early onset tumors in E2f2-/- mice is the consequence a larger pool of susceptible cells, rather than of differently behaving cells, is the finding that the lymphomas that emerged were very similar to lymphomas that arose early in E2f2+/+ Emu-myc mice. For instance, when mice showing signs of illness were sacrificed the degree of splenomegaly was comparable (Figure S9A) and the histopathology of the lymphomas was similar. The majority of early-onset tumors, either from E2f2+/+ or E2f2-/- mice, featured high mitotic indices and extensive apoptosis with tingible body macrophages and a starry sky appearance similar to that of human Burkitt lymphoma (data not shown). In addition, B lineage cells (B220+) isolated from E2f2+/+ and E2f2-/- lymphomas exhibited comparable rates of proliferation and apoptosis (Figure S9B and S9C).
###end p 40
###begin title 41
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Reduced populations of B lineage progenitors in E2f4-/- mice
###end title 41
###begin p 42
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Enos1">[40]</xref>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Rempel1">[19]</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
It has recently been shown that E2f4-deficient mice have defects that extend from early hematopoietic progenitor cells, through common lymphoid precursors and into the B and T lineages [40]. Specifically in the B lineage, E2f4-/- mice exhibit a partial block early in B lineage development prior to immunoglobulin gene rearrangement that results in a deficiency in the most mature pro-B subpopulation and a reduction in more mature B lineage cells [19] (Glozak et al., manuscript in preparation).
###end p 42
###begin p 43
###xml 93 96 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 85 96 84 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc E2f4<sup>+/+</sup></italic>
###xml 105 108 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 101 108 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/&#8722;</sup></italic>
###xml 167 170 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 163 170 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 223 226 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 253 256 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 245 256 242 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 298 301 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 391 394 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 387 394 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 473 476 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 469 476 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/+</sup></italic>
###xml 495 504 491 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g006">Figure 6A</xref>
###xml 575 578 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 616 619 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 612 619 608 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 727 730 723 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 723 730 719 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 735 738 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 756 759 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 752 759 747 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/+</sup></italic>
###xml 764 767 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 907 911 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 933 937 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 954 963 948 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g006">Figure 6B</xref>
###xml 1003 1006 996 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1058 1062 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Kelly1">[34]</xref>
###xml 1110 1113 1103 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1106 1113 1099 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1280 1283 1273 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1276 1283 1269 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1403 1406 1396 1399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1399 1406 1392 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1411 1414 1403 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1563 1566 1555 1558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1559 1566 1551 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1577 1586 1569 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g006">Figure 6C</xref>
###xml 1703 1707 1695 1699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 81 84 <span type="species:ncbi:8790">Emu</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 219 222 <span type="species:ncbi:8790">Emu</span>
###xml 241 244 <span type="species:ncbi:8790">Emu</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 294 297 <span type="species:ncbi:8790">Emu</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 731 734 <span type="species:ncbi:8790">Emu</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 760 763 <span type="species:ncbi:8790">Emu</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
###xml 999 1002 <span type="species:ncbi:8790">Emu</span>
###xml 1114 1118 <span type="species:ncbi:10090">mice</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
###xml 1407 1410 <span type="species:ncbi:8790">Emu</span>
###xml 1415 1419 <span type="species:ncbi:10090">mice</span>
###xml 1718 1722 <span type="species:ncbi:10090">mice</span>
Total viable white blood cell counts in the bone marrow were modestly higher for Emu-myc E2f4+/+ and E2f4+/- mice than for non-transgenic siblings. In the case of E2f4-/- mice, there was no increase associated with the Emu-myc transgene and Emu-myc E2f4-/- mice had about half as many cells as Emu-myc wild type siblings (p = 0.0269). As expected, within the bone marrow, non-transgenic E2f4-/- mice had a lower proportion of B lineage cells compared to non-transgenic E2f4+/+ mice (P = 0.0133, Figure 6A). Strikingly, the usual expansion of the B lineage in response to the myc transgene failed to occur in the E2f4-/- mice. As a consequence, the proportion of B lineage cells in the bone marrow was significantly less in E2f4-/- Emu-myc mice than in E2f4+/+ Emu-myc mice (P = 0.0019). Myc did, however, elicit the usual reduction in the relative proportion of mature to less mature B lineage cells in the E2f4-deficient mice as in E2f4 wild type mice (Figure 6B). Motivated by the hypothesis that Emu-myc lymphomas originate in early stage B lineage cells [34], we assessed progenitor populations in the E2f4-/- mice compared to their siblings. In CFU pre-B colony assays using bone marrow from non-transgenic E2F4 cohort mice, there were significantly fewer progenitors in E2f4-/- marrow than wild type marrow (data not shown; Glozak et al., manuscript in preparation). Notably, the pre-tumorous E2f4-/- Emu-myc mice exhibited no expansion of immature B lineage cells (B220+ CD43+) as a proportion of the total bone marrow compared to their non-transgenic E2f4-/- siblings (Figure 6C). We suggest that the Myc transgene fails to overcome the inefficient developmental progression of the B lineage in E2f4-deficient mice, there is a reduced number of susceptible progenitor cells, and consequently delayed tumor emergence.
###end p 43
###begin title 44
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
E2f4 deficiency limits expansion of the B lineage in response to Myc.
###end title 44
###begin p 45
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
(A) The percentage of B lineage cells (B220+) within the bone marrow of normal and pretumorous E2F4 cohort mice with the indicated genotypes. (B) Proportions of bone marrow B lineage cell populations (B220+), from early to more mature stages, across the E2F4 cohort: surface immunoglobulin negative cells, IgM positive IgD negative B cells, IgM positive IgD positive B cells, and IgM negative IgD positive B cells. (C) The proportion of immature B lineage cells (B220+ CD43+) in the bone marrow of non-transgenic and pretumorous E2F4 mice of the indicated genotypes.
###end p 45
###begin p 46
###xml 16 25 16 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g001">Figure 1D</xref>
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 39 42 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 341 344 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 670 673 667 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 693 696 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 720 723 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 716 723 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 728 731 724 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 805 808 801 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 823 826 818 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 846 849 841 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 842 849 837 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 884 887 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 880 887 875 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>+/+</sup></italic>
###xml 1147 1150 1142 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 1226 1229 1221 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1222 1229 1217 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1540 1543 1535 1538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1536 1543 1531 1538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1548 1551 1542 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 35 38 <span type="species:ncbi:8790">Emu</span>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 337 340 <span type="species:ncbi:8790">Emu</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 666 669 <span type="species:ncbi:8790">Emu</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 724 727 <span type="species:ncbi:8790">Emu</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 819 822 <span type="species:ncbi:8790">Emu</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 1544 1547 <span type="species:ncbi:8790">Emu</span>
###xml 1552 1556 <span type="species:ncbi:10090">mice</span>
As indicated by Figure 1D, E2f4-/- Emu-myc mice displayed a much delayed tumor onset. Possibly because of this delay, of the twenty-six mice assessed, nine died before lymphoma emergence or were still healthy at analysis. The three mice that developed lymphoma early (within 150 days of birth) and one older mouse exhibited the standard Emu-myc lymphoma phenotype, characterized by an enlarged spleen and multiple enlarged lymph nodes. Thirteen mice developed lymphoma very late in life. Three of these mice exhibited lymphoma with modest spleen enlargement and isolated lymph node enlargement, similar the uncommon late onset lymphomas that occasionally develop in Emu-myc mice wild type for E2F. The ten remaining E2f4-/- Emu-myc mice displayed an atypical tumor phenotype that was only rarely noted in E2F wild type Emu-myc mice (10 of 17 E2f4-/- mice compared to only 3 of 79 E2f4+/+ mice). These atypical tumors featured a loose tumor mass of multiple small nodules in the mediastine with little or no associated spleen or peripheral lymph node enlargement. Despite their unusual appearance, the atypical tumors that were tested demonstrated Igh gene rearrangement confirming their B lymphoid origin. Overall, eleven E2f4-/- tumors, including examples of standard, late, and atypical types, were assessed for clonality and all proved to be monoclonal. In summary, along with the general delay in tumor onset there was also a difference in the predominant site of lymphomagenesis and gross morphological appearance of tumors in the E2f4-/- Emu-myc mice.
###end p 46
###begin title 47
Distinct types of B lineage lymphoma that are influenced by the presence of E2F2 or E2F4
###end title 47
###begin p 48
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 239 242 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 354 357 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 563 567 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Mori1">[41]</xref>
###xml 656 665 654 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g007">Figure 7A</xref>
###xml 703 706 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 699 706 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 923 926 921 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 919 926 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1053 1056 1051 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1049 1056 1047 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1181 1184 1179 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1177 1184 1175 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1285 1288 1283 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1281 1288 1279 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 1312 1315 1310 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1308 1315 1306 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1492 1495 1490 1493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1488 1495 1486 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1531 1534 1529 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1582 1585 1580 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1578 1585 1576 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1629 1632 1627 1630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1625 1632 1623 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1856 1859 1854 1857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 2266 2269 2264 2267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2569 2579 2567 2577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s010">Figure S10</xref>
###xml 2582 2588 2580 2586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdkn2a</italic>
###xml 2758 2761 2756 2759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2874 2878 2872 2876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Stott1">[42]</xref>
###xml 2972 2976 2970 2974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dlk1</italic>
###xml 3072 3076 3070 3074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Raghunandan1">[43]</xref>
###xml 3077 3081 3075 3079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Sakajiri1">[44]</xref>
###xml 3086 3090 3084 3088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fzd6</italic>
###xml 3150 3154 3148 3152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Katoh1">[45]</xref>
###xml 235 238 <span type="species:ncbi:8790">Emu</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 350 353 <span type="species:ncbi:8790">Emu</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
As a further basis for exploring the effects of E2F loss of function on the development of Myc-induced tumors, we have made use of genome-scale gene expression profiles to characterize the tumors arising in the E2f2-null and E2f4-null Emu-myc mice. Our recent work has identified expression profiles that distinguish different tumor types within the Emu-myc mice including a cluster characterized by generally early onset and pre-B markers as well as three distinct clusters characterized by late onset and different sets of more differentiated B lineage markers [41]. Examples of wild type tumors exhibiting this early and late onset pattern are shown in Figure 7A. Analysis of the tumors from the E2f2-/- mice indicated that they were relatively homogeneous with respect to their expression profiles and reflected the characteristics of the "early" category of wild type tumors. In contrast, the tumor types from the E2f4-/- mice were heterogeneous with a distribution across both broad categories of the wild type tumors. The distribution of the E2f4-/- tumors corresponded with their dissection phenotypes - standard, late and atypical - described above. Three early-onset E2f4-/- tumors, all with the standard morphological phenotype, clustered with the "early" wild type and E2f2-/- tumors. Three more E2f4-/- tumors, all with the late morphological phenotype, clustered alongside a group of wild type tumors that overexpress genes characteristic of plasmacytomas. These particular E2f4-/- tumors shared marginally decreased myc mRNA and low Myc protein compared to other E2f4-/- tumors (data not shown). The final six E2f4-/- tumors were all of the atypical phenotype and segregated in the "early" category despite being late onset chronologically. These tumors shared qualities with the "early-standard" tumors in that they featured high levels of myc mRNA and Myc protein (data not shown). Notably, these tumors fell at the extreme end of the early cluster and beside a rare group of wild type tumors that had similarly modest spleen enlargement and late chronological onset. In fact, these tumors highlight a significant subgroup within the "early" category that we have designated "early-atypical". This tumor subgroup was notable for a high incidence of p53 deletion or mutation (67% of tumors assessed versus 18% of other wild type tumors assessed; by Fisher's exact test P = 0.0061). Among the genes that characterized each tumor cluster, increased expression of number of genes distinguished this subgroup from both "early-standard" and "late" clusters (Figure S10). Cdkn2a, the locus that encodes the two tumor suppressors p16(INK4a) and p19(ARF), was preferentially expressed in these tumors. Given that most of these tumors were mutant for p53, the increased expression may be a consequence of a role for p53 in negatively regulating the expression of ARF [42]. Other genes that were particularly highly expressed in the "early-atypical" tumors included Dlk1, a member of the epidermal growth factor-like family that influences B lineage differentiation [43],[44] and Fzd6, a receptor for Wnt signaling and a frizzled family member [45].
###end p 48
###begin title 49
###xml 22 25 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 18 21 <span type="species:ncbi:8790">Emu</span>
Distinct forms of Emu-myc lymphomas.
###end title 49
###begin p 50
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 68 71 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 90 93 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 108 111 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 338 341 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 334 341 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 360 363 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 356 363 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 664 667 662 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 660 667 658 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 676 679 674 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 672 679 670 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 684 687 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 860 863 856 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 875 878 871 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 913 916 909 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 909 916 905 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 945 948 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 941 948 937 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1259 1262 1255 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1255 1262 1251 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1267 1270 1262 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 64 67 <span type="species:ncbi:8790">Emu</span>
###xml 104 107 <span type="species:ncbi:8790">Emu</span>
###xml 680 683 <span type="species:ncbi:8790">Emu</span>
###xml 856 859 <span type="species:ncbi:8790">Emu</span>
###xml 1263 1266 <span type="species:ncbi:8790">Emu</span>
(A) Unsupervised hierarchical clustering of E2f2-/- and E2f4-/- Emu-myc lymphomas amongst E2F wild type Emu-myc lymphomas. Dendrogram of tumor subsets and heat map of the expression pattern of 958 genes used for the clustering analysis. Genes with sufficient variation in their expression across wild type (n = 50 plus 8 duplicates), E2f2-/- (n = 11), and E2f4-/- (n = 12) tumors were used to identify subgroups of tumors by two-way clustering. The tree classifies the tumors according to similarity of gene expression and identifies two major tumor clusters. The associated time of onset is shown by a color map (red = early onset and blue = late onset). The E2f2-/- and E2f4-/- Emu-myc lymphomas and their dissected tumor phenotypes (Standard, Atypical, and Late) are identified. (B) Pathway expression signatures that characterize the distinct forms of Emu-myc lymphomas. E2F wild type lymphomas (n = 50), E2f2-/- lymphomas (n = 11), and E2f4-/- lymphomas (n = 12) were classified on the basis of Myc pathway activity, the expression of a group of germinal-center B-cell genes, the expression of major-histocompatibility-complex class I genes, and NF-KB pathway activity. The associated dissected tumor phenotypes (Standard, Atypical, or Late) for the E2f4-/- Emu-myc lymphomas are indicated.
###end p 50
###begin p 51
###xml 52 55 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 248 252 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Dave1">[46]</xref>
###xml 466 470 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 480 484 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 538 547 533 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g007">Figure 7B</xref>
###xml 618 627 613 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g007">Figure 7A</xref>
###xml 749 753 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 897 901 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 980 983 975 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 976 983 971 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 1234 1237 1229 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 1255 1258 1250 1253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1251 1258 1246 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4<sup>&#8722;/&#8722;</sup></italic>
###xml 48 51 <span type="species:ncbi:8790">Emu</span>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
To further characterize the distinctions in the Emu-myc tumors, we have made use of signatures of various cell signaling pathways that have previously been shown to distinguish human Burkitt lymphoma (BL) from diffuse large cell B lymphoma (DLBCL) [46]. These include signatures for Myc pathway activity, the expression of a subgroup of germinal-center B-cell genes, the expression of MHC class I genes, and NFkappaB pathway activity. An analysis of tumors from the E2f2-null and E2f4-null mice using these pathway signatures is shown in Figure 7B. Consistent with the analysis of whole genome gene expression data in Figure 7A that revealed distinct types of B lymphoma, the analysis using pathway signatures also revealed that the tumors from the E2f2-null mice exhibited a pattern similar to the "early" tumors, characterized by high Myc and germinal center signatures, whereas the tumors from E2f4-null mice were heterogeneous with respect to these patterns. The atypical E2f4-/- tumors did not feature the usual "late" characteristics but instead had elevated Myc and germinal center signatures and low MHC Class I and NF-KB signatures. These tumors highlight the existence of certain tumors of late chronological onset, whether E2F wild type or E2f4-/-, that were unusual in their behavior.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 576 579 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 250 255 <span type="species:ncbi:10090">mouse</span>
###xml 572 575 <span type="species:ncbi:8790">Emu</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
A dominant characteristic of the oncogenic process is complexity - the realization that the development of a tumor results from a complex array of genetic alterations that ultimately combine to contribute to the oncogenic phenotype. While transgenic mouse models reduce this complexity by fixing one event, various studies have shown a clear heterogeneity in the tumors that develop reflecting the acquisition of additional alterations. Based on the studies we describe here, we suggest that there are at least two distinct types of B lineage lymphoma that develop in the Emu-myc mice. In mice with wild type E2F function, the predominant tumor arising with an early onset likely reflects the relative abundance of the target cell population. We suggest that the emergence of these tumors reflects a stochastic acquisition of additional mutations. Since this is a probabilistic event, there is then an opportunity for tumors to emerge from other populations of cells with characteristics distinct from the "early-standard" tumors. We propose that the late-onset tumors develop more slowly because the target cell populations are less abundant. It is also possible that these late-onset tumors are genetically more complex, requiring more mutations than the predominant form of tumors.
###end p 53
###begin p 54
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Rempel1">[19]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Enos1">[40]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Humbert1">[47]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Kinross1">[49]</xref>
###xml 1001 1004 1000 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 997 1000 <span type="species:ncbi:8790">Emu</span>
The work we present here provides clear evidence for an interaction between Myc and two E2Fs as seen by the effect on timing of tumor onset and the different characteristics of the lymphomas that arise in the absence of E2F2 or E2F4. The results suggest distinct roles for the E2F2 and E2F4 proteins in the process of B lineage development that then impacts Myc-mediated oncogenesis. A role for E2F4 in cell differentiation is consistent with past work that documented abnormalities in hematopoietic lineage development as well as the development of the gut and nasal epithelia with loss of E2F4 activity [19], [40], [47]-[49]. This past work revealed a deficiency of various mature hematopoietic cell types and defects in the differentiation of immature cells in the absence of E2F4. Taken together, these observations suggest a critical role for E2F4 activity in controlling the maturation of hematopoietic lineage cells, including the B lymphoid compartment that generates the target cells for Emu-myc-induced lymphomagenesis.
###end p 54
###begin p 55
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Li1">[50]</xref>
###xml 984 988 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Zhu1">[51]</xref>
###xml 989 993 989 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Murga1">[52]</xref>
###xml 1115 1119 1115 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
A role for E2F2 appears to be more complex. E2F2 has generally been characterized as one of the E2Fs involved in the activation of transcription of genes essential for cell proliferation. While the other two activating E2Fs (E2F1 and E2F3) appear to be broadly expressed, E2F2 expression is largely restricted to cells of the hematopoietic lineage. Indeed, previous work has pointed to a role for E2F2 in the function and development of various hematopoietic lineages. S-phase progression is impaired in B, erythroid, and myeloid lineages in the absence of E2F1 and E2F2, consistent with a role for these E2F products as positive regulators of cell proliferation [50]. Nevertheless, the possibility of a more complex role for E2F2 in hematopoietic cells emerged from studies demonstrating that the loss of E2F2 appears to enhance the proliferation of T cells following antigenic stimulation, suggesting a negative role for E2F2 in defining a threshold for Ag-stimulated proliferation [51],[52]. Although this latter observation is not consistent with the results we present here regarding proliferative capacity in E2f2-null B lineage cells, it certainly is true that with Myc overexpression, the absence of E2F2 function may accelerate tumor onset by increasing the proportion of progenitor B lineage populations.
###end p 55
###begin p 56
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Opavsky1">[25]</xref>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3</italic>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 420 423 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 520 524 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 621 625 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 742 746 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 922 925 921 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 918 925 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 937 940 936 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 933 940 932 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>+/+</sup></italic>
###xml 969 973 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 1164 1173 1163 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g003">Figure 3A</xref>
###xml 1178 1188 1177 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s009">Figure S9C</xref>
###xml 416 419 <span type="species:ncbi:8790">Emu</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 1091 1095 <span type="species:ncbi:10090">mice</span>
Opavsky and colleagues have recently used a bitransgenic model of Myc-induced T cell lymphomagenesis to probe the importance of E2F1, E2F2 and E2F3 for Myc activities [25]. Analogous to our findings for B lineage lymphomagenesis, they found that E2f1 or E2f3 deficiencies have no effect on T cell lymphoma progression. Most importantly, E2f2 deficiency accelerates tumor onset in the T cell model as it does for the Emu-myc model. In addition, other aspects of their findings are reminiscent of our results, namely that E2f2 heterozygotes have an intermediate phenotype, suggesting some haploinsufficiency, and that with E2f2 deficiency there is an increased incidence of multiple tumor clones. The salient difference is that in their study, E2f2 deficiency is associated with reduced apoptosis. Specifically, Opavsky and colleagues detected a reduced percentage of annexin-positive T cells in moribund mice that were E2f2-/- versus E2f2+/+ whereas in our experiments, E2f2 deficiency was not associated with reduced apoptosis, whether assessing the bulk of B lineage cells from pretumorous mice, or when looking at B220+ cells isolated from tumorous lymph nodes (Figure 3A and Figure S9C).
###end p 56
###begin p 57
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Baudino1">[23]</xref>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 159 163 159 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 377 380 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 414 418 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Baudino1">[23]</xref>
###xml 557 560 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 373 376 <span type="species:ncbi:8790">Emu</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 553 556 <span type="species:ncbi:8790">Emu</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
In marked contrast to the study of Baudino et al. [23], the work described here did not demonstrate that E2f1 deficiency influenced lymphoma development or p27Kip1 regulation. This discrepancy could be the consequence of the different knockout alleles utilized and possible differences in strain background and breeding strategies. But we also note that the wild type E2f1 Emu-myc mice in the Baudino et al. study [23] exhibit a more precipitous and overall earlier tumor-onset curve than reported in most other studies with C57BL/6 congenic, wild type Emu-myc mice.
###end p 57
###begin title 58
Developmental effects that influence the outcome of oncogenesis
###end title 58
###begin p 59
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 244 247 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 290 293 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 286 293 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 446 450 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 738 741 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 734 741 733 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2<sup>&#8722;/&#8722;</sup></italic>
###xml 240 243 <span type="species:ncbi:8790">Emu</span>
Our results indicate that E2f2 deficiency enhances the emergence of the "early-standard" form of lymphoma likely because the absence of E2F2 activity expands the population of cells that is the usual target for the oncogenic process in the Emu-myc model. As a result, the population of E2f2-/- tumors is also more homogeneous with respect to their phenotype, as reflected by the gene expression profiles. In contrast, we propose that the loss of E2f4 results in the decrease of this population of cells and thus the frequency of appearance of standard morphology early onset tumors. There is not a complete absence of these cells since a few tumors do arise in the absence of E2F4 that cluster with the "early-standard" wild type and E2f2-/- tumors. But the consequence of this depletion is enrichment for tumors with a late chronological onset, whether to the extreme of the "early" cluster or in the "late" cluster, likely due to an opportunity for these tumors to develop because of the reduced frequency of the "early-standard" variety. Taken together, these results point to a role for E2F activities in determining the population of B lineage cells that contribute to the development of tumors and highlights the interplay between two cell regulatory activities, E2F and Myc, in determining the outcome of the oncogenic process.
###end p 59
###begin title 60
Materials and Methods
###end title 60
###begin title 61
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse strains and tumor monitoring
###end title 61
###begin p 62
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Rempel1">[19]</xref>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Field1">[28]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Wu1">[53]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
Mice were housed in a Duke University Medical Center Division of Laboratory Animal Resources facility and experiments approved by the Duke University Institutional Animal Care and Use Committee. The generation of the specific lines of E2F-deficient mice has been previously described [19],[28],[53]. The original 129 substrain background was 129/SvJae for the E2F1, E2F2 and E2F3 cohorts and 129/OlaHsd for the E2F4 cohort. Based on breeding history, the E2F1 cohort mice used in this study were predominantly C57BL/6 (backcrossed five generations into C57BL/6) while the E2F2, E2F3 and E2F4 cohorts were mixed C57BL/6x129. The four E2F cohorts were maintained separately and breeding involved crossing heterozygous mice to yield wild type, heterozygous and null mice in each generation.
###end p 62
###begin p 63
###xml 8 11 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 40 43 39 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Adams1">[5]</xref>
###xml 276 279 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 329 332 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 325 332 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2Fn<sup>+/&#8722;</sup></italic>
###xml 373 376 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 390 393 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 386 393 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2fn<sup>+/&#8722;</sup></italic>
###xml 457 460 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 464 465 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 453 465 450 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2fn<sup>+/&#8722;</sup> myc<sup>+</sup></italic>
###xml 489 492 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 496 497 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 485 497 482 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2fn<sup>+/&#8722;</sup> myc<sup>&#8722;</sup></italic>
###xml 515 518 511 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 555 558 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 551 558 547 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2fn<sup>+/+</sup></italic>
###xml 564 567 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 560 567 556 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2fn<sup>+/&#8722;</sup></italic>
###xml 577 580 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 573 580 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2fn<sup>&#8722;/&#8722;</sup></italic>
###xml 666 670 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Kelly1">[34]</xref>
###xml 696 699 691 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 764 767 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 841 844 835 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 4 7 <span type="species:ncbi:8790">Emu</span>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 272 275 <span type="species:ncbi:8790">Emu</span>
###xml 369 372 <span type="species:ncbi:8790">Emu</span>
###xml 511 514 <span type="species:ncbi:8790">Emu</span>
###xml 692 695 <span type="species:ncbi:8790">Emu</span>
###xml 760 763 <span type="species:ncbi:8790">Emu</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
The Emu-myc transgenic mouse line 292-1 [5] extensively backcrossed into C57BL/6 and originally from Dr. Alan Harris (Walter and Eliza Hall Institute, Melbourne, Australia), was kindly provided by Dr. Scott Lowe (Cold Spring Harbor Laboratory). For each E2F cohort, stock Emu-myc positive C57BL/6 congenic males were bred to E2Fn+/- females and of the progeny only the Emu-myc positive E2fn+/- males, designated the F1 males, were kept. These F1 males, E2fn+/- myc+, were then bred to E2fn+/- myc- females. The Emu-myc positive progeny of this cross, E2fn+/+, E2fn+/-, and E2fn-/- were then compared. Because maternal transmission is associated with reduced latency [34], transmission of the Emu-myc transgene was exclusively paternal in this breeding scheme. Emu-myc negative siblings were also kept as a source of related mice that lacked myc transgene effects.
###end p 63
###begin p 64
###xml 4 7 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 0 3 <span type="species:ncbi:8790">Emu</span>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">Mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
Emu-myc positive mice were monitored weekly to identify any mice with malignant disease. Mice were evaluated for any visible or palpable lumps, a hunched posture, tachypnea, a swollen belly, or ruffled fur and sacrificed promptly upon the appearance of any such symptoms. Lymphomas that emerged were dissected from sacrificed mice, washed in PBS, and frozen in liquid nitrogen or processed for flow cytometric analysis. The frozen tissue provided material for Southern and western analysis.
###end p 64
###begin title 65
Statistical analysis
###end title 65
###begin p 66
Tumor onset data refer to the time in days between birth and the first indication of illness. Using GraphPad's Prism program, the time values were plotted to generate Kaplan-Meier survival curves and the curves compared by a logrank test. For comparisons of means and standard deviations, the paired student t-test was performed and statistical significance was determined if the p<0.05.
###end p 66
###begin title 67
Western analysis
###end title 67
###begin p 68
###xml 778 782 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Leone3">[54]</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
To assess alterations in p19ARF, Mdm2 and p53 protein expression, lymphoma samples were dissected from morbid mice and immediately frozen. Samples were then weighed, ground to a powder in liquid nitrogen and resuspended in 60 mM Tris (pH 6.8)/1% SDS at 1 ml per 0.2 g tumor weight, boiled, sonicated, and any remaining debris removed by centrifugation. In parallel, whole cell extracts were made from mouse embryonic fibroblasts infected with the indicated adenoviruses for controls. Protein was quantitated using the BCA Protein Assay Reagent Kit (Pierce). Samples (150 microg) were boiled in sample buffer and subjected to SDS-PAGE on 8.5% polyacrylamide gels for p53 and Mdm2 assessment and 15% gels for ARF assessment. Western analysis was performed as previously described [54]. The blots were probed with antibodies specific for p53 (monoclonal antibody Ab-1 OP03 at 1:1000, Calbiochem), p19ARF (polyclonal antibody Ab-1 PC435 at 1:10,000, Calbiochem), and Mdm2 (polyclonal antibody C-18 sc812 at 1:1000, Santa Cruz Biotechnology). Equal protein loading was verified by staining blots with Ponceau Red (0.2% ponceau red in 3% trichloroacetic acid).
###end p 68
###begin title 69
Southern analysis
###end title 69
###begin p 70
###xml 142 145 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 157 160 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 169 172 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Afl</italic>
###xml 184 190 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19ARF</italic>
###xml 201 204 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 364 367 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 473 476 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 514 517 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 645 649 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Sidman2">[37]</xref>
###xml 380 385 <span type="species:ncbi:9606">human</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
Genomic DNA was isolated from lymphomas, normal spleen cells, tail samples and MEFs of specified genotypes. DNA (10 microg) was digested with BamH1 (for the p53 locus), AflII (for the p19ARF locus) or EcoRI (for the heavy chain locus). The restricted DNA was separated by agarose gel electrophoresis (0.8% gels), transferred to Hybond N+ membrane, and probed. The p53 probe was a human cDNA fragment (686 base pair DrdI-StuI fragment extending from exon 4 to exon 10). The ARF probe was the exon 1B portion of the ARF cDNA (kindly provided by Charles Sherr). The heavy chain locus probe was the heavy chain J3-J4 joining region genomic fragment [37]. On occasion, to verify that weanling mice were essentially tumor-free, genomic DNA isolated from B lineage cells was assessed by Southern analysis for any emergence of clonal heavy chain rearrangements.
###end p 70
###begin title 71
FACS analysis
###end title 71
###begin p 72
Mononuclear cells were harvested from the bone marrow of 3-week-old littermates and from lymphomas that arose. Cells were stained with various combinations of antibodies to IgD (11-26c.2a), IgM (R6-60.2), CD19 (1D3), B220 (RA3-6B2), CD43 (S7), BrdU, and active caspase-3. All antibodies and staining reagents were from BD Biosciences. Cell staining procedures were performed either manually or using a Biomek 2000 robotic fluid handler (Beckman Instruments, Schaumburg, IL using a series of mini-programs developed with BioWorks software (Beckman Instruments). FACS analysis was performed on a FACSCalibur device equipped with a 488 nm argon laser and a approximately635 nm red dye laser (Becton Dickinson (BD), San Jose, CA). Data was analyzed using FlowJo Software (TreeStar, Palo Alto, Ca).
###end p 72
###begin title 73
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Cell cycle analysis of B lineage cells from normal and pretumorous mice
###end title 73
###begin p 74
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Three hours before analysis, mice were injected with 100 mg/kg BrdU. Bone marrow mononuclear cells were collected and stained with the B220 and CD19 antibodies to identify B lineage cells, with 7-AAD, and with anti-BrdU antibodies. BrdU Flow Kit reagents and directions were followed (BD/Pharmingen). The proportion of cells that had proceeded through S-phase, or resided in G0/G1 or in G2/M phases was determined.
###end p 74
###begin title 75
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Viability assessment in culture of B lineage cells from normal and pretumorous mice
###end title 75
###begin p 76
###xml 615 616 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 167 172 <span type="species:ncbi:10090">Mouse</span>
Hematopoietic cells were harvested from the bone marrow, spleen and mesenteric lymph node, combined and enriched for B lineage cells using negative selection (SpinSep Mouse B Cell Enrichment Cocktail, Stem Cell Technologies). The antibodies used to label unwanted cell types for depletion were directed against CD4, CD8, CD11b, CD49b, Gr-1, TER119 and CD43. The approach yielded a subset of B lineage cells from the small pre-B stage through more mature stages. These cells were cultured at 37degreesC for eight hours in DMEM plus 10%FCS/100 microM L-aspargine/50 microM 2-mercaptoethanol at a concentration of 4x106 cells/ml. At selected time points cells were removed and stained with 7-AAD and B220 antibody, fixed and permeabilized, stained with activated caspase-3 antibody and analyzed by flow cytometry. Viable cells were negative for both 7-AAD and activated caspase-3.
###end p 76
###begin title 77
CFU Pre-B assays
###end title 77
###begin p 78
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 272 277 <span type="species:ncbi:10090">mouse</span>
###xml 438 444 <span type="species:ncbi:9913">bovine</span>
Equivalent numbers of bone marrow cells from non-transgenic 4-6 week old mice were resuspended in Methocult M3630 (Stemcell Technologies) according to manufacturer's specifications to assay for pre-B cell colonies. This media, formulated for the detection and counting of mouse pre-B progenitors in bone marrow, is comprised of methylcellulose in Iscove's MDM supplemented with recombinant IL-7, 2-Mercaptoethanol, L-glutamine, and fetal bovine serum. All samples were assayed in duplicate. After seven days colonies were counted using an inverted microscope. The count was based on the manufacturer's description of expected colony appearance - namely that colonies are composed of at least 30 cells and that individual cells are tiny and irregular to oval in shape.
###end p 78
###begin title 79
DNA microarray analysis
###end title 79
###begin p 80
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Johnson1">[55]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Bild1">[56]</xref>
###xml 259 264 <span type="species:ncbi:10090">Mouse</span>
RNA was extracted from lymphoma samples using Qiagen RNeasy Kits (Qiagen). RNA sample integrity was verified by agarose gel electrophoresis or using an Agilent 2100 Bioanalyser. We prepared the targets for DNA microarray analysis and hybridized to Affymetrix Mouse 430 2.0 GeneChip arrays according to the manufacturer's instructions and as previously published. To allow merging of expression array results from samples arrayed independently, some duplicate samples were arrayed to provide reference samples and the expression values standardized using ComBat [55]. The method for cross-platform comparison across different versions of Affymetrix GeneChip arrays was described previously [56].
###end p 80
###begin title 81
Statistical analyses of microarray data
###end title 81
###begin p 82
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Bild1">[56]</xref>
Hierarchical clustering and visualization were performed using Gene Cluster 3.0 () and Java TreeView (). Genes and tumors were clustered by average linkage using uncentered correlation as the similarity metric. Analysis of expression data was described previously [56]. In summary, we collected training sets consisting of gene expression values of samples where the pathway activity was known. We created gene expression signatures by choosing the genes whose expression profiles across the training samples most highly correlated with the phenotype. Then, to predict the status of the phenotype on a tumor expression dataset, we fit a Bayesian probit regression model that assigned the probability that a tumor sample exhibited evidence of the phenotype, based on the concordance of its gene expression values with the signature.
###end p 82
###begin p 83
###xml 54 61 54 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s011">Text S1</xref>
The Supporting Materials and Methods are available in Text S1.
###end p 83
###begin title 84
Supporting Information
###end title 84
###begin p 85
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f1</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3a</italic>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f3b</italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f4</italic>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
Tissue-specific expression of E2F family members. (A) Comparison of the relative expression of i) E2f1 mRNA, ii) E2f2 mRNA, iii) E2f3a and E2f3b mRNAs, and iv) E2f4 mRNA across several tissue types with the expression in bone marrow set to one. Tissues: BM-bone marrow, S-spleen, T-thymus, M-mammary gland, O-ovary, U-uterus, Lu-lung, and Br-brain. (B) Western blot analysis of E2F2 protein in tissues from wild type and matched E2f2-null mice. (C) Western blot analysis of E2F4 protein in tissues from wild type and matched E2f4-null mice.
###end p 85
###begin p 86
(0.96 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 38 41 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 84 92 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc E2Fn</italic>
###xml 185 188 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 302 305 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 337 344 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc E2F</italic>
###xml 34 37 <span type="species:ncbi:8790">Emu</span>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 80 83 <span type="species:ncbi:8790">Emu</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 181 184 <span type="species:ncbi:8790">Emu</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 298 301 <span type="species:ncbi:8790">Emu</span>
###xml 333 336 <span type="species:ncbi:8790">Emu</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
Kaplan-Meier survival analysis of Emu-myc C57BL/6 congenic mice compared to the Emu-myc E2Fn wild type mice. (A) Kaplan-Meier survival analysis showing the percentage of tumor-free Emu-myc C57BL/6 congenic mice plotted against the onset of disease. (B) Kaplan-Meier survival analysis comparing the Emu-myc C57BL/6 congenics with the Emu-myc E2F wild type mice from the various cohorts.
###end p 88
###begin p 89
(0.22 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 133 137 133 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F1</italic>
###xml 503 506 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 218 233 <span type="species:ncbi:10090">transgenic mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 499 502 <span type="species:ncbi:8790">Emu</span>
###xml 518 522 <span type="species:ncbi:10090">Mice</span>
Myc-induced degradation of p27Kip1 and promotion of proliferation appear independent of E2F1 status. (A) Western blot analysis of p27Kip1 in B lineage cells isolated from the spleens of non-transgenic sibling mice and transgenic mice progressing to illness, and from lymphomas. Note that actin levels decrease with disease progression while tubulin levels increase with disease progression. (B) Splenic B lineage cell proliferation in E2F1 wild type, heterozygous and null mice with and without the Emu-myc transgene. Mice were injected with BrdU, spleens harvested fourteen hours later, and the incorporation of BrdU into DNA in splenic B lineage cells (B220+) assessed by flow cytometry.
###end p 91
###begin p 92
(0.78 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 508 511 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 504 507 <span type="species:ncbi:8790">Emu</span>
Flow cytometric analysis of cultured B lineage cells to assess viability on the basis of staining for activated caspase 3 and 7AAD.' B lineage cells (small pre-B and more mature cells) were isolated from the bone marrow, spleen, and mesenteric lymph node and then cultured without cytokines. At indicated times cells were sampled from the cultures and stained for flow cytometry. The boxed region identifies viable B220+ cells. Note that at time zero there were more caspase-positive cells isolated from Emu-myc positive animals than from non-transgenics and that over time caspase-positive cells shifted to becoming 7-AAD positive as well.
###end p 94
###begin p 95
(0.74 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 207 210 207 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 321 324 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 367 370 366 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 449 452 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 475 478 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 562 565 561 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Eischen1">[8]</xref>
###xml 624 627 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
###xml 211 216 <span type="species:ncbi:9606">human</span>
###xml 363 366 <span type="species:ncbi:8790">Emu</span>
Southern analysis of the p53 locus in normal tail DNA, MEF DNA, and tumor DNA. (A) A 6 kb species and a larger 10 kb pseudogene species were detected upon probing a BamHI digest of mouse genomic DNA using a p53 human cDNA probe (exons 4 to 10). (B) The mobility of the p53 locus fragment was altered in DNA isolated from p53-/- MEFs. (C) The screening of several Emu-myc lymphoma samples and identification of a single tumor, #14, as having deleted p53. Overall, deletion of p53 was rare in the tumors we assessed, in keeping with the findings of Eischen et al. [8]. The larger 10 kb pseudogene species was unchanged in the p53-/- MEFs or any of the tumors and provided a convenient loading control.
###end p 97
###begin p 98
(1.57 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Afl</italic>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 197 200 197 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Eischen1">[8]</xref>
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 301 304 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 340 349 340 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000640.s005">Figure S5</xref>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 402 405 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 424 427 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</italic>
###xml 398 401 <span type="species:ncbi:8790">Emu</span>
Southern analysis of the ARF locus in normal tail DNA and tumor DNA. (A) A 7.8 kb fragment representing the ARF locus was detected when tail DNA was digested with AflII and probed with ARF exon 1B [8]. (B) Assessment of several tumors for ARF locus deletion. Tumor #15 exhibited biallelic deletion of ARF, while tumor #14, deleted for p53 (Figure S5), retained ARF. (C) The screening of additional Emu-myc tumor samples for ARF deletion.
###end p 100
###begin p 101
(1.40 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 69 72 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 183 187 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F1</italic>
###xml 277 281 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Kowalik1">[13]</xref>
###xml 380 383 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 517 520 515 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Eischen1">[8]</xref>
###xml 627 630 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 753 756 750 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 937 940 934 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000640-Eischen1">[8]</xref>
###xml 65 68 <span type="species:ncbi:8790">Emu</span>
###xml 376 379 <span type="species:ncbi:8790">Emu</span>
###xml 749 752 <span type="species:ncbi:8790">Emu</span>
Immunoblot analysis of p53, ARF, and Mdm2 expression in MEFs and Emu-myc tumors. (A) p53 protein was assessed in MEFs infected with either control adenovirus or adenovirus expressing E2F1, and in several tumor samples. Forced overexpression of E2F1 induces accumulation of p53 [13], and the same species was evident in one of the tumors. The p53 protein overexpressed in some Emu-myc tumors represents mutant forms that accumulate to very high levels because they fail to induce Mdm2 to trigger their own destruction [8]. (B) ARF protein was assessed in MEFs infected with various recombinant adenoviruses, one of which was Ad-Arf, and, in several tumors, some of which overexpress ARF. (C) p53, ARF, and Mdm2 expression assessed in the same set of Emu-myc tumors. While no specific controls were used for Mdm2 protein, assorted species of the expected size and complexity were identified using the antibody referenced by Eischen et al. [8]. In common with earlier studies, p53 overexpression was associated with ARF overexpression, ARF overexpression also occurred independently in additional tumors, and Mdm2 overexpression patterns were complex.
###end p 103
###begin p 104
(1.97 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 123 126 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 945 954 945 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000640-g005">Figure 5A</xref>
###xml 1285 1288 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 1324 1328 1324 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 1336 1340 1336 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 1340 1343 1340 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1348 1351 1347 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1344 1347 <span type="species:ncbi:8790">Emu</span>
Tumor clonality as determined by Igh locus rearrangement patterns. (A) Normal spleen DNA and tumor DNAs were digested with EcoRI, agarose gel fractionated, and Southern analysis performed using a heavy chain joining region probe. The arrow indicates the 6.5 kb germline fragment in normal spleen DNA, while in tumor samples additional bands were evident, representing rearranged Igh alleles. Most commonly, in addition to the residual germline band, there were two equimolar fragments bearing the heavy chain joining region that resulted from recombination at both Igh alleles (see tumor 2 and tumor 4). The single rearranged fragment seen for tumor 1 probably reflects two co-migrating fragments. In the case of tumor 3, the dominance of the germline band suggests that the sample largely comprised normal cells, and indeed the notes describing the dissection suggested that lymphoma had barely initiated. As described in the figure legend for Figure 5A, lymphomas were characterized as monoclonal if there were zero, one, or two bands in addition to any germline band, as biclonal if there were three or four bands in addition to any germline band, and oligoclonal if there were five or more bands in addition to any germline band. (B) As an additional example of this analysis, the Igh rearrangement patterns for several E2f2+/+ and E2f2-/- Emu-myc tumors are displayed.
###end p 106
###begin p 107
(1.25 MB TIF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 38 41 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 126 130 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 144 148 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 166 170 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2f2</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 34 37 <span type="species:ncbi:8790">Emu</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 196 211 <span type="species:ncbi:10090">transgenic mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
The E2f2-/- mice exhibit standard Emu-myc lymphoma. (A) Comparison at time of dissection of spleen weights from tumor-bearing E2f2+/+ (n = 18), E2f2+/- (n = 23), and E2f2-/- (n = 16) mice and non-transgenic mice (n = 9). (B) Proliferation of B lineage (B220+) lymphoma cells. Tumorous mice were injected with BrdU and two hours later lymphomas dissected. BrdU incorporation into the DNA of B220+ lymphoma cells was assessed by flow cytometry. (C) Apoptosis of B lineage (B220+) lymphoma cells. Freshly isolated lymphoma cells and normal lymph node cells were isolated and stained with 7-AAD and antibodies to B220 and activated caspase 3. B220+ cells were designated as apoptotic if positive for activated caspase 3 and either negative or positive for 7-AAD.
###end p 109
###begin p 110
(0.21 MB TIF)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
The expression pattern of genes associated with the Expression levels are displayed with genes as rows and samples as columns and shown by a heatmap in which high expression is indicated by red and low expression by green.
###end p 112
###begin p 113
(0.36 MB TIF)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
Supporting materials and methods.
###end p 115
###begin p 116
(0.06 MB DOC)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin title 118
References
###end title 118
###begin article-title 119
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
###end article-title 119
###begin article-title 120
###xml 34 39 <span type="species:ncbi:9606">human</span>
The consensus coding sequences of human breast and colorectal cancers.
###end article-title 120
###begin article-title 121
Characterizing the cancer genome in lung adenocarcinoma.
###end article-title 121
###begin article-title 122
###xml 26 31 <span type="species:ncbi:9606">human</span>
The genomic landscapes of human breast and colorectal cancers.
###end article-title 122
###begin article-title 123
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
###end article-title 123
###begin article-title 124
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally.
###end article-title 124
###begin article-title 125
Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation.
###end article-title 125
###begin article-title 126
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
###end article-title 126
###begin article-title 127
The regulation of E2F by pRB-family proteins.
###end article-title 127
###begin article-title 128
The E2F family: specific functions and overlapping interests.
###end article-title 128
###begin article-title 129
The Rb/E2F pathway and cancer.
###end article-title 129
###begin article-title 130
p14ARF links the tumour suppressors RB and p53.
###end article-title 130
###begin article-title 131
E2F1-specific induction of apoptosis and p53 accumulation is modulated by mdm2.
###end article-title 131
###begin article-title 132
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
###end article-title 132
###begin article-title 133
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
###end article-title 133
###begin article-title 134
Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals.
###end article-title 134
###begin article-title 135
p27kip1-independent cell cycle regulation by MYC.
###end article-title 135
###begin article-title 136
Myc requires distinct E2F activities to induce S phase and apoptosis.
###end article-title 136
###begin article-title 137
Loss of E2F4 activity leads to abnormal development of multiple cellular lineages.
###end article-title 137
###begin article-title 138
A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting.
###end article-title 138
###begin article-title 139
###xml 70 76 <span type="species:ncbi:10090">murine</span>
Expression patterns of the E2F family of transcription factors during murine epithelial development.
###end article-title 139
###begin article-title 140
###xml 4 7 <span type="species:ncbi:8790">Emu</span>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
The Emu-myc transgenic mouse. A model for high incidence spontaneous lymphoma and leukemia of early B cells.
###end article-title 140
###begin article-title 141
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
###end article-title 141
###begin article-title 142
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
###end article-title 142
###begin article-title 143
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
###end article-title 143
###begin article-title 144
###xml 19 22 <span type="species:ncbi:8790">Emu</span>
###xml 27 42 <span type="species:ncbi:10090">transgenic mice</span>
Genetic studies on Emu-myc transgenic mice.
###end article-title 144
###begin article-title 145
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tumor induction and tissue atrophy in mice lacking E2F-1.
###end article-title 145
###begin article-title 146
###xml 19 23 <span type="species:ncbi:10090">mice</span>
E2F-1 functions in mice to promote apoptosis and suppress proliferation.
###end article-title 146
###begin article-title 147
c-Myc enhances protein synthesis and cell size during B lymphocyte development.
###end article-title 147
###begin article-title 148
Induction of apoptosis in fibroblasts by c-myc protein.
###end article-title 148
###begin article-title 149
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
###end article-title 149
###begin article-title 150
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Bim is a suppressor of Myc-induced mouse B cell leukemia.
###end article-title 150
###begin article-title 151
Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
###end article-title 151
###begin article-title 152
###xml 56 59 <span type="species:ncbi:8790">Emu</span>
Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.
###end article-title 152
###begin article-title 153
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain.
###end article-title 153
###begin article-title 154
Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis.
###end article-title 154
###begin article-title 155
###xml 49 64 <span type="species:ncbi:10090">transgenic mice</span>
Multiple mechanisms of tumorigenesis in E mu-myc transgenic mice.
###end article-title 155
###begin article-title 156
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
###end article-title 156
###begin article-title 157
###xml 74 89 <span type="species:ncbi:10090">transgenic mice</span>
T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
###end article-title 157
###begin article-title 158
E2F4 modulates differentiation and gene expression in hematopoietic progenitor cells during commitment to the lymphoid lineage.
###end article-title 158
###begin article-title 159
###xml 80 83 <span type="species:ncbi:8790">Emu</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emu-myc model and human DLBCL.
###end article-title 159
###begin article-title 160
###xml 33 38 <span type="species:ncbi:9606">human</span>
The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2.
###end article-title 160
###begin article-title 161
Dlk1 influences differentiation and function of B lymphocytes.
###end article-title 161
###begin article-title 162
Dlk1 in normal and abnormal hematopoiesis.
###end article-title 162
###begin article-title 163
Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis.
###end article-title 163
###begin article-title 164
Molecular diagnosis of Burkitt's lymphoma.
###end article-title 164
###begin article-title 165
E2F4 is essential for normal erythrocyte maturation and neonatal viability.
###end article-title 165
###begin article-title 166
E2F4 is required for normal development of the airway epithelium.
###end article-title 166
###begin article-title 167
E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation.
###end article-title 167
###begin article-title 168
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.
###end article-title 168
###begin article-title 169
E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.
###end article-title 169
###begin article-title 170
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity.
###end article-title 170
###begin article-title 171
The E2F1-3 transcription factors are essential for cellular proliferation.
###end article-title 171
###begin article-title 172
E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.
###end article-title 172
###begin article-title 173
Adjusting batch effects in microarray expression data using empirical Bayes methods.
###end article-title 173
###begin article-title 174
###xml 32 37 <span type="species:ncbi:9606">human</span>
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
###end article-title 174
###begin p 175
The authors have declared that no competing interests exist.
###end p 175
###begin p 176
The source of funding for this work is the National Institutes of Health, grant 5-RO1-CA-106520-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 176

